The European Union landed on Amsterdam as the new home for the European Medicines Agency headquarters, following three rounds of voting and a tiebreaker against Milan. The agency hopes to keep a majority of its existing staff in the move.
The relocation presents an additional challenge for EMA as it implements the EU’s new medical device and IVD regulations.
The decision leaves just 16 months for the EMA and its 900 staff to complete the move from its current location in London’s Canary Wharf. Operations must be up and running in the capital of the Netherlands by March 30, 2019.